×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

GCC Closed System Drug Transfer Device Market

ID: MRFR/Pharma/47917-HCR
200 Pages
Rahul Gotadki
October 2025

GCC Closed System Drug Transfer Device Market Research Report By Type (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

GCC Closed System Drug Transfer Device Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

GCC Closed System Drug Transfer Device Market Summary

As per MRFR analysis, the GCC closed system-drug-transfer-device market Size was estimated at $60.0 Million in 2024. The GCC closed system-drug-transfer-device market is projected to grow from 66.1 $ Million in 2025 to 174.16 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 10.17% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The GCC closed system-drug-transfer-device market is poised for growth driven by regulatory compliance and technological advancements.

  • The market is witnessing increased regulatory compliance, which is shaping operational standards across healthcare facilities.
  • Technological advancements are enhancing the efficiency and safety of drug transfer processes, particularly in oncology and pharmacy segments.
  • The oncology segment remains the largest, while the pharmacy segment is emerging as the fastest-growing due to rising safety concerns.
  • Key market drivers include the rising demand for safe drug handling and government initiatives aimed at improving occupational safety.

Market Size & Forecast

2024 Market Size 60.0 (USD Million)
2035 Market Size 174.16 (USD Million)
CAGR (2025 - 2035) 10.17%

Major Players

Baxter International Inc (US), B. Braun Melsungen AG (DE), Cardinal Health Inc (US), Cypress Medical Products LLC (US), ICU Medical Inc (US), Merit Medical Systems Inc (US), Pall Corporation (US), Terumo Corporation (JP)

GCC Closed System Drug Transfer Device Market Trends

The closed system-drug-transfer-device market is currently experiencing notable growth within the GCC region. This expansion is largely driven by increasing awareness regarding safety protocols in healthcare settings. Healthcare professionals are increasingly recognizing the importance of minimizing exposure to hazardous drugs, which has led to a heightened demand for effective drug transfer solutions. Furthermore, regulatory bodies in the GCC are emphasizing the need for stringent safety measures, thereby propelling the adoption of closed system-drug-transfer-devices across hospitals and clinics. As a result, manufacturers are innovating and enhancing their product offerings to meet these evolving standards, which may further stimulate market growth. In addition, the closed system-drug-transfer-device market is witnessing advancements in technology that enhance usability and efficiency. The integration of smart technologies into these devices appears to be a key trend, as it allows for better monitoring and control during drug transfer processes. This technological evolution not only improves safety but also streamlines operations within healthcare facilities. As the market continues to evolve, stakeholders are likely to focus on developing user-friendly solutions that cater to the specific needs of healthcare providers in the GCC region, ensuring that safety and efficiency remain at the forefront of drug transfer practices.

Increased Regulatory Compliance

Regulatory bodies in the GCC are implementing stricter guidelines regarding the handling of hazardous drugs. This trend is pushing healthcare facilities to adopt closed system-drug-transfer-devices to comply with safety standards, thereby reducing the risk of exposure to harmful substances.

Technological Advancements

The closed system-drug-transfer-device market is seeing a surge in technological innovations. Manufacturers are integrating smart features into devices, which enhance monitoring and control during drug transfer, ultimately improving safety and operational efficiency.

Growing Awareness of Safety Protocols

There is a rising awareness among healthcare professionals about the importance of safety protocols in drug handling. This awareness is driving the demand for closed system-drug-transfer-devices, as they provide a safer alternative for managing hazardous drugs.

GCC Closed System Drug Transfer Device Market Drivers

Surge in Cancer Cases

The rising incidence of cancer in the GCC region is a critical driver for the closed system-drug-transfer-device market. As cancer rates continue to climb, healthcare providers are increasingly focused on ensuring the safe administration of chemotherapy and other hazardous drugs. The market is projected to grow as hospitals and clinics invest in closed system-drug-transfer-devices to protect healthcare workers and patients alike. Reports indicate that the number of cancer cases in the GCC is expected to increase by 20% over the next decade, further emphasizing the need for effective drug transfer solutions. This growing patient population is likely to propel the closed system-drug-transfer-device market forward.

Government Initiatives and Funding

Government initiatives aimed at enhancing healthcare infrastructure in the GCC region significantly impact the closed system-drug-transfer-device market. Increased funding for healthcare facilities encourages the adoption of advanced medical technologies, including closed system-drug-transfer-devices. For instance, initiatives to improve oncology care have led to a surge in demand for these devices, as they are essential for safe drug administration. The market is expected to benefit from government policies that promote the use of safety-engineered devices, potentially leading to a market growth rate of around 7% in the coming years. This support from governmental bodies is crucial for the expansion of the closed system-drug-transfer-device market.

Rising Demand for Safe Drug Handling

The closed system-drug-transfer-device market experiences a notable increase in demand driven by the need for safe drug handling practices. Healthcare facilities in the GCC region are increasingly adopting these devices to minimize the risk of exposure to hazardous drugs. This trend is particularly evident in oncology departments, where the handling of cytotoxic drugs is prevalent. The market is projected to grow at a CAGR of approximately 8% over the next five years, reflecting the heightened focus on safety and compliance. As hospitals and clinics prioritize patient and staff safety, the closed system-drug-transfer-device market is likely to expand, with investments in advanced technologies becoming commonplace.

Increased Focus on Occupational Safety

The growing emphasis on occupational safety within healthcare settings significantly influences the closed system-drug-transfer-device market. Regulatory bodies and healthcare organizations are prioritizing the protection of healthcare workers from exposure to hazardous drugs. This focus is leading to the implementation of stringent safety protocols, which in turn drives the demand for closed system-drug-transfer-devices. The market is likely to experience a growth trajectory of around 5% as healthcare facilities invest in safety measures to comply with regulations. This heightened awareness of occupational safety is crucial for the advancement of the closed system-drug-transfer-device market.

Technological Integration in Healthcare

The integration of advanced technologies in healthcare is reshaping the closed system-drug-transfer-device market. Innovations such as smart devices and automated systems enhance the efficiency and safety of drug handling processes. As healthcare facilities in the GCC adopt these technologies, the demand for closed system-drug-transfer-devices is expected to rise. The market may witness a growth rate of approximately 6% as hospitals seek to streamline operations and reduce the risk of contamination. This technological shift not only improves patient outcomes but also aligns with the broader trend of digital transformation in healthcare, thereby positively influencing the closed system-drug-transfer-device market.

Market Segment Insights

By Type: Membrane-To-Membrane Systems (Largest) vs. Needleless Systems (Fastest-Growing)

In the GCC closed system-drug-transfer-device market, Membrane-To-Membrane Systems dominate the market share due to their established presence and reliability in drug transfer applications. These systems appeal to healthcare providers looking for effective and safe solutions for drug delivery. Conversely, Needleless Systems, while currently possessing a smaller share, are rapidly gaining traction as innovative technologies are introduced to the market. The growth trends for this segment indicate a shift towards Needleless Systems, driven by advancements in medical technology and an increased emphasis on patient safety. As healthcare facilities look to reduce the risk of needle-stick injuries and enhance overall efficiency, Needleless Systems are poised for significant expansion. This trend reflects a broader movement within the healthcare industry towards minimizing invasive procedures and embracing safer alternatives in drug administration.

Technology: Membrane-To-Membrane Systems (Dominant) vs. Needleless Systems (Emerging)

Membrane-To-Membrane Systems are characterized by their robust design and effectiveness in ensuring secure drug transfer, making them the preferred choice for many healthcare institutions. Their established track record and reliability in various medical applications underscore their dominant market position. In contrast, Needleless Systems represent an emerging technology that prioritizes safety and ease of use, catering to the increasing demand for less invasive medical procedures. These systems utilize innovative mechanisms to deliver drug substances without needles, which aligns with current healthcare trends focused on minimizing risks associated with traditional drug transfer methods. As both segments evolve, the competition between these technologies is likely to shape the future landscape of drug transfer devices.

By Component: Vial Access Devices (Largest) vs. Syringe Safety Devices (Fastest-Growing)

In the GCC closed system-drug-transfer-device market, the Component segment showcases a diverse array of products including Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, and Accessories. Among these, Vial Access Devices command the largest market share, reflecting their established presence and widespread adoption in healthcare settings. Syringe Safety Devices, while currently smaller in market share, exhibit significant potential for growth, driven by increasing awareness of safety protocols and the need for innovative solutions. As the overall demand for safe drug transfer mechanisms rises, the growth trends within the Component segment are notable. Factors contributing to the rise include technological advancements in drug delivery systems, stringent regulatory requirements, and an increasing number of patients requiring injectable medications. Furthermore, the market is experiencing a shift towards more sophisticated safety devices that ensure the well-being of healthcare professionals and patients alike, propelling Syringe Safety Devices to become the fastest-growing segment.

Vial Access Devices (Dominant) vs. Accessories (Emerging)

Vial Access Devices are recognized as the dominant force within the Component segment in the GCC closed system-drug-transfer-device market. Their robust design and effectiveness in facilitating drug transfer without compromising sterility set them apart from competitors. These devices are preferred for their reliability and compliance with healthcare standards, making them a vital choice for hospitals and pharmacies. On the other hand, Accessories represent the emerging market segment, showcasing innovative solutions that enhance the functionality of primary devices. These include various types of connectors, adaptors, and protective aids that streamline the drug transfer process. As healthcare facilities seek to improve operational efficiency and product performance, the demand for Accessories is steadily increasing, positioning them as a critical component of future market growth.

By Closing Mechanism: Push To Turn System (Largest) vs. Click-To Lock System (Fastest-Growing)

The market for closing mechanisms within the GCC closed system-drug-transfer-device market is dominated by the Push To Turn System, which holds a significant share due to its reliability and ease of use. Following closely are Color-To-Color Alignment Systems and Leur Lock Systems, which cater to specific user preferences in clinical environments. However, Click-To Lock Systems are carving a niche, appealing to users who prioritize quick engagement and secure locking.

Push To Turn System (Dominant) vs. Click-To Lock System (Emerging)

The Push To Turn System is recognized as the dominant player in the GCC closed system-drug-transfer-device market, primarily due to its user-friendly design and robust locking mechanism, which ensures safety during drug transfer. In contrast, the Click-To Lock System is emerging rapidly, appealing to modern healthcare facilities that seek efficient and quick operational procedures. This system is gaining traction for its fast engagement capabilities, thus enhancing workflow in critical scenarios. Both systems reflect the diverse needs of healthcare providers in ensuring secure and effective drug delivery mechanisms.

By Technology: Compartmentalize Devices (Largest) vs. Diaphragm-Based Devices (Fastest-Growing)

In the GCC closed system-drug-transfer-device market, Compartmentalize Devices hold a significant market share, making them the dominant choice among healthcare providers. These devices offer robust protection against contamination, which is crucial in drug handling, leading to a higher adoption rate. On the other hand, Diaphragm-Based Devices are gaining traction due to their innovative designs and efficiency, appealing to facilities looking to enhance safety and operational performance. The growth trends for these technologies are driven by increasing investments in healthcare infrastructure and a rising awareness of safety protocols in drug transfer processes. As regulatory standards become more stringent, the demand for reliable and efficient closed systems continues to rise. The emergence of new entrants in the market also stimulates competition, promoting technological advancements and expanding the range of available options to consumers.

Technology: Compartmentalize Devices (Dominant) vs. Diaphragm-Based Devices (Emerging)

Compartmentalize Devices are characterized by their superior ability to isolate and securely transfer hazardous drugs, making them the preferred choice in environments where safety is paramount. These devices are well-established in the market, supported by extensive research and positive user feedback. Conversely, Diaphragm-Based Devices represent an emerging trend, focusing on facilitating ease of use while maintaining high safety standards. Their innovative approach is appealing to new market entrants, establishing them as strong contenders. As healthcare facilities prioritize efficiency, both segments are expected to evolve, catering to the growing needs of the sector.

By End User: Hospitals & Clinics (Largest) vs. Specialty Centers (Fastest-Growing)

In the GCC closed system-drug-transfer-device market, the segmentation by end user reveals that hospitals and clinics hold the largest share, driven by their extensive use of drug transfer devices in various medical procedures. Specialty centers, while currently smaller in market share, are rising quickly due to their focus on niche medical fields and the increasing demand for specialized healthcare solutions. The growth trends in this segment are significantly influenced by advancements in medical technology and an increasing emphasis on patient safety and medication integrity. Hospitals and clinics continuously adapt to new regulations, while specialty centers leverage cutting-edge innovations in drug delivery systems, creating a dynamic landscape. The rising prevalence of chronic diseases and the increasing complexity of drug therapies also fuel the growth of specialty centers, making them an essential part of this market.

Hospitals & Clinics (Dominant) vs. Specialty Centers (Emerging)

Hospitals and clinics dominate the end user segment of the GCC closed system-drug-transfer-device market due to their vital role in inpatient and outpatient care. They require reliable and efficient drug transfer systems to ensure patient safety and reduce the risk of contamination. On the other hand, specialty centers represent an emerging segment, focusing on specific treatments such as oncology, endocrinology, and pain management. These centers are increasingly adopting advanced drug transfer technologies to enhance treatment efficacy and patient outcomes. Their growth is further propelled by a shift towards personalized medicine and the need for precise drug administration, positioning them to compete strongly against established hospitals and clinics in the coming years.

Get more detailed insights about GCC Closed System Drug Transfer Device Market
Request Free Sample

Key Players and Competitive Insights

The closed system-drug-transfer-device market is currently characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include the increasing emphasis on patient safety, regulatory compliance, and the rising prevalence of chronic diseases. Major players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and ICU Medical Inc (US) are strategically positioned to leverage innovation and technological advancements. Baxter International Inc (US) focuses on enhancing its product portfolio through continuous research and development, while B. Braun Melsungen AG (DE) emphasizes regional expansion and partnerships to strengthen its market presence. ICU Medical Inc (US) appears to be concentrating on digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological integration and strategic collaborations.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure is moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and solutions, catering to various healthcare needs. The collective strategies of these companies indicate a trend towards consolidation and collaboration, as they seek to enhance their competitive edge in a rapidly evolving market.

In October 2025, Baxter International Inc (US) announced a strategic partnership with a leading technology firm to develop advanced drug delivery systems that integrate AI capabilities. This move is significant as it positions Baxter at the forefront of innovation, potentially enhancing patient outcomes and operational efficiencies. The integration of AI into drug delivery systems may streamline processes and reduce the risk of medication errors, thereby reinforcing Baxter's commitment to patient safety.

In September 2025, B. Braun Melsungen AG (DE) launched a new line of closed system-drug-transfer devices designed specifically for oncology applications. This product launch is noteworthy as it addresses a critical need in the market, catering to the growing demand for safe and effective drug delivery solutions in cancer treatment. By focusing on oncology, B. Braun is likely to capture a significant share of this niche market, further solidifying its competitive position.

In August 2025, ICU Medical Inc (US) expanded its manufacturing capabilities by investing in a new facility dedicated to the production of closed system-drug-transfer devices. This expansion is indicative of ICU Medical's commitment to meeting the increasing demand for these devices, particularly in the GCC region. By enhancing its production capacity, ICU Medical is poised to improve supply chain reliability and respond more effectively to market needs.

As of November 2025, current competitive trends in the closed system-drug-transfer-device market include a strong focus on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovation, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the market.

Key Companies in the GCC Closed System Drug Transfer Device Market market include

Industry Developments

Recent developments in the GCC Closed System Drug Transfer Device Market are marked by an increasing focus on safety and efficiency in drug handling due to the rising awareness of occupational exposure risks among healthcare professionals.

Notably, major players like Becton Dickinson and BD Medical are expanding their product lines to include more advanced solutions that comply with newly established regulatory guidelines aimed at enhancing safety standards in administering hazardous drugs.

In terms of market dynamics, an uptick in hospital acquisitions and consolidation within the healthcare sector across the GCC has led to greater demand for high-quality Closed System Drug Transfer Devices by providers seeking to improve patient care and operational efficiencies.

Additionally, in June 2022, C.R. Bard acquired a local firm in the GCC region, bolstering its market presence and enhancing its capabilities in drug delivery technology.

The overall market valuation is anticipated to grow significantly as investments in healthcare infrastructure increase across GCC nations, such as Saudi Arabia and the UAE, as part of their national Vision 2030 initiatives. These developments reflect a strategic shift towards improving healthcare outcomes and safety protocols within the region.

Future Outlook

GCC Closed System Drug Transfer Device Market Future Outlook

The Closed System Drug Transfer Device Market is projected to grow at 10.17% CAGR from 2024 to 2035, driven by increasing safety regulations and demand for efficient drug delivery systems.

New opportunities lie in:

  • Development of integrated telehealth solutions for remote patient monitoring.
  • Expansion of product lines to include customizable drug transfer devices.
  • Partnerships with healthcare providers for on-site training and support services.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

GCC Closed System Drug Transfer Device Market Type Outlook

  • Membrane-To-Membrane Systems
  • Needleless Systems

GCC Closed System Drug Transfer Device Market End User Outlook

  • Hospitals & clinics
  • Specialty centers
  • Others

GCC Closed System Drug Transfer Device Market Component Outlook

  • Vial Access Devices
  • Syringe Safety Devices
  • Bag/Line Access Devices
  • Accessories

GCC Closed System Drug Transfer Device Market Technology Outlook

  • Compartmentalize Devices
  • Diaphragm-Based Devices
  • Air Filtration Devices

GCC Closed System Drug Transfer Device Market Closing Mechanism Outlook

  • Push To Turn System
  • Color-To-Color Alignment System
  • Leur Lock Systems
  • Click-To Lock System

Report Scope

MARKET SIZE 202460.0(USD Million)
MARKET SIZE 202566.1(USD Million)
MARKET SIZE 2035174.16(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)10.17% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["Baxter International Inc (US)", "B. Braun Melsungen AG (DE)", "Cardinal Health Inc (US)", "Cypress Medical Products LLC (US)", "ICU Medical Inc (US)", "Merit Medical Systems Inc (US)", "Pall Corporation (US)", "Terumo Corporation (JP)"]
Segments CoveredType, Component, Closing Mechanism, Technology, End User
Key Market OpportunitiesGrowing demand for safety and efficiency in hazardous drug handling presents opportunities in the closed system-drug-transfer-device market.
Key Market DynamicsRising regulatory scrutiny drives innovation and adoption of closed system-drug-transfer-devices in the GCC healthcare sector.
Countries CoveredGCC

Leave a Comment

FAQs

What is the expected market size of the GCC Closed System Drug Transfer Device Market in 2024?

The market is expected to be valued at 90.0 USD Million in 2024.

What will be the projected market value of the GCC Closed System Drug Transfer Device Market by 2035?

By 2035, the market is anticipated to reach a value of 600.0 USD Million.

What is the expected compound annual growth rate (CAGR) for the GCC Closed System Drug Transfer Device Market from 2025 to 2035?

The expected CAGR for the market is 18.823% during the period from 2025 to 2035.

Which type will dominate the GCC Closed System Drug Transfer Device Market by 2035?

The Needleless System is projected to dominate the market, reaching a value of 360.0 USD Million by 2035.

What is the market value for the Membrane to Membrane segment in 2024?

The Membrane to Membrane segment is valued at 42.0 USD Million in 2024.

Who are the key players in the GCC Closed System Drug Transfer Device Market?

Major players include Becton Dickinson, C.R. Bard, Medline Industries, and West Pharmaceutical Services, among others.

What challenges may affect the growth of the GCC Closed System Drug Transfer Device Market?

Challenges may include regulatory hurdles and concerns regarding product efficacy and safety.

What opportunities exist within the GCC Closed System Drug Transfer Device Market?

Opportunities include innovations in drug delivery systems and expansion into emerging markets.

What is the anticipated impact of emerging trends on the GCC Closed System Drug Transfer Device Market?

Emerging trends towards safety and efficiency in drug transfer are expected to drive market growth significantly.

How does regionality affect the GCC Closed System Drug Transfer Device Market growth?

Regionality influences the market based on varying healthcare infrastructure and regulatory policies across GCC countries.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓